Loading...
GE HealthCare Technologies Inc.
GEHCV•NASDAQ
Healthcare
Medical - Healthcare Information Services
$56.00
$-2.38(-4.08%)
GE HealthCare Technologies Inc. (GEHCV) Financial Performance & Statements
Review GE HealthCare Technologies Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.61%
↑ 0.61%
Operating Income Growth
7.80%
↑ 7.80%
Net Income Growth
27.10%
↑ 27.10%
Operating Cash Flow Growth
-7.14%
↓ 7.14%
Operating Margin
13.99%
↑ 13.99%
Gross Margin
41.96%
↑ 41.96%
Net Profit Margin
11.03%
↑ 11.03%
ROE
25.87%
↑ 25.87%
ROIC
11.73%
↑ 11.73%
GE HealthCare Technologies Inc. (GEHCV) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for GE HealthCare Technologies Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.32B | $4.86B | $4.84B | $4.65B |
| Cost of Revenue | $3.04B | $2.84B | $2.84B | $2.75B |
| Gross Profit | $2.27B | $2.02B | $2.00B | $1.90B |
| Gross Profit Ratio | $0.43 | $0.42 | $0.41 | $0.41 |
| R&D Expenses | $344.00M | $316.00M | $327.00M | $324.00M |
| SG&A Expenses | $1.13B | $1.03B | $1.004B | $1.04B |
| Operating Expenses | $1.47B | $1.35B | $1.33B | $1.36B |
| Total Costs & Expenses | $4.52B | $4.19B | $4.17B | $4.11B |
| Interest Income | $0.00 | $5.00M | $0.00 | $0.00 |
| Interest Expense | $111.00M | $130.00M | $131.00M | $138.00M |
| Depreciation & Amortization | $140.00M | $143.00M | $150.00M | $148.00M |
| EBITDA | $1.08B | $933.00M | $862.00M | $792.00M |
| EBITDA Ratio | $0.20 | $0.19 | $0.17 | $0.17 |
| Operating Income | $801.00M | $676.00M | $664.00M | $540.00M |
| Operating Income Ratio | $0.15 | $0.14 | $0.14 | $0.12 |
| Other Income/Expenses (Net) | $33.00M | -$18.00M | -$86.00M | -$28.00M |
| Income Before Tax | $834.00M | $658.00M | $578.00M | $512.00M |
| Income Before Tax Ratio | $0.16 | $0.14 | $0.12 | $0.11 |
| Income Tax Expense | $96.00M | $168.00M | $143.00M | $124.00M |
| Net Income | $720.00M | $471.00M | $428.00M | $374.00M |
| Net Income Ratio | $0.14 | $0.10 | $0.09 | $0.08 |
| EPS | $1.58 | $1.03 | $0.94 | $0.82 |
| Diluted EPS | $1.57 | $1.02 | $0.93 | $0.81 |
| Weighted Avg Shares Outstanding | $457.00M | $457.00M | $457.00M | $456.00M |
| Weighted Avg Shares Outstanding (Diluted) | $459.00M | $459.00M | $459.00M | $459.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan